Literature DB >> 19188620

Drug development cost estimates hard to swallow.

Roger Collier.   

Abstract

Mesh：

Year:  2009        PMID： 19188620      PMCID： PMC2630351          DOI： 10.1503/cmaj.082040

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  18 in total

1.  Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder.

Authors:  Boadie W Dunlop; Thomas Li; Susan G Kornstein; Edward S Friedman; Anthony J Rothschild; Ron Pedersen; Philip Ninan; Martin Keller; Madhukar H Trivedi
Journal:  J Psychiatr Res       Date:  2010-06-02       Impact factor: 4.791

2.  Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm.

Authors:  Roland B Walter; Frederick R Appelbaum; Martin S Tallman; Noel S Weiss; Richard A Larson; Elihu H Estey
Journal:  Blood       Date:  2010-06-10       Impact factor: 22.113

3.  Medicinal chemistry for 2020.

Authors:  Seetharama D Satyanarayanajois; Ronald A Hill
Journal:  Future Med Chem       Date:  2011-10       Impact factor: 3.808

4.  The Expected Net Present Value of Developing Weight Management Drugs in the Context of Drug Safety Litigation.

Authors:  Anita Chawla; Ginger Carls; Edmund Deng; Edward Tuttle
Journal:  Pharmacoeconomics       Date:  2015-07       Impact factor: 4.981

5.  EFFICACY-TO-EFFECTIVENESS CLINICAL TRIALS.

Authors:  Harry P Selker; Sheeona Gorman; Kenneth I Kaitin
Journal:  Trans Am Clin Climatol Assoc       Date:  2018

6.  Applications for oncologic drugs: a descriptive analysis of the oncologic drugs advisory committee reviews.

Authors:  John K Chan; Tuyen K Kiet; Bradley J Monk; Nichole Young-Lin; Kevin Blansit; Daniel S Kapp; Idoroenyi Amanam
Journal:  Oncologist       Date:  2014-03-05

7.  Ethical issues for control-arm patients after revelation of benefits of experimental therapy: a framework modeled in neuroblastoma.

Authors:  Yoram Unguru; Steven Joffe; Conrad V Fernandez; Alice L Yu
Journal:  J Clin Oncol       Date:  2013-01-07       Impact factor: 44.544

Review 8.  "Quantum Leap" in Photobiomodulation Therapy Ushers in a New Generation of Light-Based Treatments for Cancer and Other Complex Diseases: Perspective and Mini-Review.

Authors:  Luis Santana-Blank; Elizabeth Rodríguez-Santana; Karin E Santana-Rodríguez; Heberto Reyes
Journal:  Photomed Laser Surg       Date:  2016-02-18       Impact factor: 2.796

9.  Use of microdosing and accelerator mass spectrometry to evaluate the pharmacokinetic linearity of a novel tricyclic GyrB/ParE inhibitor in rats.

Authors:  Michael A Malfatti; Victoria Lao; Courtney L Ramos; Voon S Ong; Kenneth W Turteltaub
Journal:  Antimicrob Agents Chemother       Date:  2014-08-18       Impact factor: 5.191

10.  Testing for efficacy in adaptive clinical trials with enrichment.

Authors:  Samuel S Wu; Yi-Hsuan Tu; Ying He
Journal:  Stat Med       Date:  2014-02-27       Impact factor: 2.373
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.